Monthly Archives: May 2012

CETP Inhibitors: Blockbusters that Never Ran?

By Ben Comer | Published: May 7, 2012
The news that Roche scrapped development on its CETP inhibitor dalcetrapib, a drug designed to raise HDL cholesterol in the blood, likely presages the shuttering of Lilly’s development program for its CETP inhibitor, evacetrapib, industry experts and analysts say.
Posted in Biotech, R&D, Technology, leadership | Tagged , , , , , , , | Leave a comment

Heady Ideas for Digital Health Marketing

By Ben Comer | Published: May 1, 2012
If you really want to know what’s on a patient’s mind, it’s best to skip the small talk and go straight to the brain waves, as demonstrated by Neuro Insight CEO Pranav Yadav in the lead-off presentation yesterday at Chandler Chicco’s Pioneers in Digital Health conference.
Posted in Advertising, Agency Insight, E-Media, Events, Marketing, Patient Communication, Sales, Strategy, Technology, leadership, social media | Tagged , , , , , , , | Leave a comment

Less is More: HHS Austerity Care

By Guest Blogger | Published: May 1, 2012
By Tom Norton As the US Department of Health and Human Services (HHS) circles around the elements of health care that will actually be included in our new “Essential Health Benefits” (EHB), one aspect of the EHB offering has caused a tremendous stir among dozens of health groups.  Their collective concern is focused on the pharmaceutical [...]
Posted in Guest Blog, Legal, Regulatory, compliance, healthcare | Tagged , , , , , , , , | Leave a comment